Originators

Originator is a biotechnology company focused on developing next-generation cell therapies using induced pluripotent stem cell (iPSC) technology. The company aims to create "off-the-shelf" cellular medicines that can be manufactured at scale and delivered to patients more efficiently than traditional autologous therapies. Their research primarily targets oncology and autoimmune indications, leveraging advanced genetic engineering to enhance the persistence and efficacy of their cell products. By utilizing a standardized iPSC platform, Originator seeks to overcome the logistical and cost barriers associated with personalized cell treatments.